BCIP Life Sciences Associates, LP

Track

Insider profile

BCIP Life Sciences Associates, LP's trades of NewAmsterdam Pharma Company NV's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-12-02 2025-12-02
PrS Proposed sale
72,781
30.70
US$26,708 		72,781 30.70 US$26,708
2025-07-24 2025-07-24
US Nuvalent Inc (NUVL)
PrS Proposed sale
18,694
43.73
US$3,836,110 		18,694 43.73 US$3,836,110
2024-12-11 2024-12-11
US Nuvalent Inc (NUVL)
PrS Proposed sale
75,031
230.89
US$760,315 		75,031 230.89 US$760,315
2023-10-24 2023-10-24
PrS Proposed sale
38,113
13.81
US$526,341 		38,113 13.81 US$526,341
2023-10-10 2023-10-10
PrS Proposed sale
46,428
14.73
US$683,884 		46,428 14.73 US$683,884
2023-08-08 2023-08-08
PrS Proposed sale
139,283
14.75
US$2,054,424 		139,283 14.75 US$2,054,424
2023-06-14 2023-06-14
PrS Proposed sale
46,428
12.56
US$583,136 		46,428 12.56 US$583,136
2023-05-18 2023-05-18
PrS Proposed sale
92,855
11.13
US$1,033,476 		92,855 11.13 US$1,033,476